ROSUVASTATIN CALCIUM

ROSUVASTATIN CALCIUM was reported 29384 times

ROSUVASTATIN CALCIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FRACTIONAL EXHALED NITRIC OXIDE INCREASED 91 0.5084
1 RHINITIS PERENNIAL 28 0.3500
2 MALIGNANT MEDIASTINAL NEOPLASM 35 0.3182
3 RHEUMATOID FACTOR NEGATIVE 55 0.3143
4 HYPER IGE SYNDROME 32 0.2807
5 REVERSIBLE AIRWAYS OBSTRUCTION 141 0.2776
6 NEUROLOGIC NEGLECT SYNDROME 153 0.2752
7 CONGENITAL HIATUS HERNIA 60 0.2632
8 GAIT SPASTIC 85 0.2478
9 BLOOD MERCURY ABNORMAL 24 0.2449
10 SPIROMETRY ABNORMAL 144 0.2408
11 MITE ALLERGY 155 0.2366
12 VITAL CAPACITY DECREASED 96 0.2143
13 CAROTID ARTERY THROMBOSIS 155 0.1826
14 NEEDLE FATIGUE 80 0.1751
15 MYCOTIC ALLERGY 145 0.1696
16 DUST ALLERGY 153 0.1560
17 ADJUSTMENT DISORDER 186 0.1431
18 SEDATION COMPLICATION 351 0.1374
19 MYCOBACTERIUM TEST POSITIVE 26 0.1262
20 SPUTUM CULTURE POSITIVE 95 0.1170
21 HUMAN RHINOVIRUS TEST POSITIVE 43 0.1153
22 CONJUNCTIVITIS ALLERGIC 154 0.1039
23 RELAPSING-REMITTING MULTIPLE SCLEROSIS 80 0.0926
24 PULMONARY VASCULITIS 49 0.0911
25 CREATININE RENAL CLEARANCE DECREASED 361 0.0901
26 NASAL OEDEMA 161 0.0890
27 VIRAL TEST POSITIVE 32 0.0882
28 LUNG DIFFUSION TEST DECREASED 32 0.0802
29 OBSTRUCTIVE SLEEP APNOEA SYNDROME 117 0.0802
30 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 73 0.0787
31 BRONCHIAL SECRETION RETENTION 100 0.0785
32 TOTAL LUNG CAPACITY ABNORMAL 30 0.0771
33 MULTIPLE DRUG THERAPY 58 0.0769
34 PNEUMONIA HAEMOPHILUS 36 0.0741
35 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 28 0.0737
36 MYOGLOBIN BLOOD INCREASED 108 0.0706
37 RESPIRATORY GAS EXCHANGE DISORDER 26 0.0701
38 BLOOD PRESSURE DIASTOLIC ABNORMAL 177 0.0695
39 ENDOMETRIAL DISORDER 28 0.0678
40 BLOOD PRESSURE SYSTOLIC ABNORMAL 155 0.0627
41 RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE 44 0.0626
42 CONGESTIVE HEPATOPATHY 28 0.0625
43 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 137 0.0594
44 PERSONALITY DISORDER 153 0.0584
45 MULTI-ORGAN DISORDER 108 0.0549
46 FULL BLOOD COUNT ABNORMAL 572 0.0540
47 STEROID DEPENDENCE 47 0.0535
48 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 109 0.0534
49 OBSTRUCTIVE AIRWAYS DISORDER 587 0.0527
50 BLOOD IMMUNOGLOBULIN A DECREASED 34 0.0522
51 BLOOD IMMUNOGLOBULIN M INCREASED 31 0.0510
52 CREATININE RENAL CLEARANCE INCREASED 38 0.0508
53 TOTAL LUNG CAPACITY DECREASED 80 0.0501
54 RESTRICTIVE PULMONARY DISEASE 56 0.0478
55 BURSITIS INFECTIVE 25 0.0460
56 NORMOCHROMIC NORMOCYTIC ANAEMIA 138 0.0459
57 MONOPARESIS 80 0.0442
58 BONE EROSION 156 0.0441
59 ENTEROCOCCUS TEST POSITIVE 28 0.0432
60 BRONCHIECTASIS 283 0.0420
61 PERIORBITAL PAIN 35 0.0413
62 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 30 0.0409
63 FORCED VITAL CAPACITY DECREASED 25 0.0383
64 BLOOD IMMUNOGLOBULIN G INCREASED 46 0.0378
65 CATARRH 34 0.0376
66 DRUG SPECIFIC ANTIBODY 49 0.0358
67 HYPERTONIC BLADDER 102 0.0353
68 CAROTID ARTERIOSCLEROSIS 36 0.0349
69 PSEUDOMONAL BACTERAEMIA 29 0.0340
70 BLOOD CALCIUM DECREASED 379 0.0337
71 BRAIN NATRIURETIC PEPTIDE INCREASED 100 0.0324
72 NEURITIS 50 0.0324
73 ARTERIOSCLEROSIS CORONARY ARTERY 210 0.0317
74 ENDOCRINE OPHTHALMOPATHY 27 0.0311
75 LUNG OPACITY 78 0.0296
76 INJECTION SITE SCAB 28 0.0290
77 PLANTAR FASCIITIS 97 0.0289
78 DYSLIPIDAEMIA 146 0.0287
79 GANGRENE 173 0.0287
80 PERIPHERAL SENSORIMOTOR NEUROPATHY 36 0.0286
81 MALIGNANT MELANOMA IN SITU 35 0.0282
82 EYELID PAIN 57 0.0280
83 BLOOD PRESSURE SYSTOLIC INCREASED 526 0.0269
84 PULMONARY FUNCTION TEST ABNORMAL 42 0.0269
85 NASAL DISCHARGE DISCOLOURATION 37 0.0268
86 INFUSION SITE DISCHARGE 46 0.0262
87 BLOOD IMMUNOGLOBULIN E INCREASED 63 0.0260
88 MULTIPLE ALLERGIES 194 0.0247
89 ARTERIAL OCCLUSIVE DISEASE 193 0.0245
90 EOSINOPHIL COUNT INCREASED 203 0.0243
91 ORTHOSTATIC HYPOTENSION 419 0.0240
92 SERONEGATIVE ARTHRITIS 27 0.0236
93 UPPER-AIRWAY COUGH SYNDROME 194 0.0235
94 RHEUMATIC DISORDER 45 0.0233
95 C-REACTIVE PROTEIN ABNORMAL 145 0.0226
96 BLOOD PRESSURE DIASTOLIC DECREASED 163 0.0221
97 POLYCYSTIC OVARIES 34 0.0219
98 SENSORY LOSS 175 0.0217
99 CHRONIC SPONTANEOUS URTICARIA 25 0.0216
100 RESPIRATORY SYMPTOM 61 0.0214
101 WHEEZING 1265 0.0213
102 SINUS PAIN 49 0.0210
103 SINUS CONGESTION 283 0.0209
104 JOINT NOISE 41 0.0209
105 BODY TEMPERATURE DECREASED 200 0.0203
106 BLOOD PRESSURE DIASTOLIC INCREASED 93 0.0201
107 MYELOPATHY 38 0.0200
108 MAST CELL ACTIVATION SYNDROME 28 0.0199
109 RALES 115 0.0198
110 HEMIPLEGIA 164 0.0197
111 MUSCLE SPASTICITY 241 0.0196
112 BURNS SECOND DEGREE 34 0.0194
113 LOW DENSITY LIPOPROTEIN DECREASED 27 0.0191
114 AFFECT LABILITY 182 0.0189
115 TONGUE BITING 38 0.0184
116 FORCED EXPIRATORY VOLUME DECREASED 52 0.0183
117 PLEURITIC PAIN 50 0.0181
118 RESPIRATORY TRACT INFECTION 463 0.0178
119 PRODUCTIVE COUGH 841 0.0176
120 SPUTUM DISCOLOURED 167 0.0176
121 BREATH SOUNDS ABNORMAL 86 0.0174
122 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 291 0.0171
123 DRUG TOLERANCE DECREASED 48 0.0171
124 PULMONARY MASS 253 0.0170
125 ARTERIOSCLEROSIS 159 0.0169
126 GOITRE 67 0.0163
127 NASAL ULCER 26 0.0163
128 BENIGN PROSTATIC HYPERPLASIA 84 0.0163
129 HAEMOGLOBIN INCREASED 74 0.0162
130 SKIN HAEMORRHAGE 234 0.0158
131 RESPIRATORY TRACT CONGESTION 248 0.0156
132 MOTOR DYSFUNCTION 159 0.0156
133 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 26 0.0156
134 MYOPATHY 131 0.0152
135 ASTHMA 1711 0.0151
136 SKIN LACERATION 160 0.0147
137 NODULE 192 0.0147
138 HYPERCHOLESTEROLAEMIA 141 0.0146
139 SEASONAL ALLERGY 206 0.0145
140 INFUSION SITE BRUISING 31 0.0143
141 INFUSION SITE PRURITUS 45 0.0142
142 SEDATION 372 0.0142
143 IMMUNE-MEDIATED MYOSITIS 39 0.0141
144 ENDOMETRIOSIS 67 0.0140
145 BLOOD PRESSURE FLUCTUATION 335 0.0139
146 SINUS DISORDER 274 0.0138
147 MICTURITION URGENCY 154 0.0135
148 RHEUMATOID FACTOR POSITIVE 77 0.0133
149 HYPOPNOEA 46 0.0132
150 SACROILIITIS 25 0.0132
151 AORTIC ARTERIOSCLEROSIS 34 0.0132
152 INFUSION SITE HAEMORRHAGE 43 0.0131
153 MYCOBACTERIUM AVIUM COMPLEX INFECTION 35 0.0130
154 RED CELL DISTRIBUTION WIDTH INCREASED 54 0.0130
155 RHABDOMYOLYSIS 539 0.0129
156 DYSPNOEA EXERTIONAL 484 0.0128
157 ALCOHOL POISONING 34 0.0127
158 RENAL FUNCTION TEST ABNORMAL 58 0.0125
159 COORDINATION ABNORMAL 173 0.0124
160 EXOSTOSIS 113 0.0124
161 HAEMATOCRIT INCREASED 28 0.0123
162 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 580 0.0121
163 SNEEZING 270 0.0120
164 THYROID DISORDER 185 0.0120
165 SECRETION DISCHARGE 150 0.0120
166 TROPONIN INCREASED 91 0.0119
167 INFUSION SITE SWELLING 75 0.0119
168 SENSATION OF FOREIGN BODY 100 0.0119
169 DEVICE INFUSION ISSUE 29 0.0117
170 HEPATIC NEOPLASM 38 0.0116
171 CYSTITIS 369 0.0116
172 COLITIS MICROSCOPIC 54 0.0114
173 BLOOD TEST ABNORMAL 160 0.0114
174 TENOSYNOVITIS 31 0.0112
175 BLOOD PRESSURE SYSTOLIC DECREASED 51 0.0112
176 PULMONARY FUNCTION TEST DECREASED 49 0.0112
177 LIPOMA 29 0.0112
178 INFUSION SITE ERYTHEMA 94 0.0111
179 BLOOD COUNT ABNORMAL 168 0.0111
180 HYPERKERATOSIS 61 0.0110
181 INGROWING NAIL 26 0.0110
182 CARDIAC MURMUR 95 0.0110
183 BLOOD CALCIUM INCREASED 96 0.0109
184 BLOOD IMMUNOGLOBULIN G DECREASED 27 0.0109
185 PARANASAL SINUS DISCOMFORT 41 0.0108
186 MALNUTRITION 120 0.0107
187 FIBROSIS 33 0.0107
188 NOCTURIA 130 0.0107
189 SCOLIOSIS 66 0.0106
190 OEDEMA 575 0.0106
191 ANGINA PECTORIS 303 0.0106
192 RED BLOOD CELL SEDIMENTATION RATE INCREASED 117 0.0106
193 OBSTRUCTION 42 0.0105
194 HEMIPARESIS 177 0.0104
195 HYPOVENTILATION 34 0.0104
196 EOSINOPHILIA 182 0.0104
197 FINE MOTOR SKILL DYSFUNCTION 30 0.0104
198 INFUSION SITE PAIN 132 0.0102
199 EATING DISORDER 217 0.0102
200 MICTURITION DISORDER 35 0.0101
201 BURSITIS 122 0.0100
202 PULMONARY FIBROSIS 191 0.0099
203 SPINAL STENOSIS 41 0.0099
204 COGNITIVE DISORDER 462 0.0099
205 OXYGEN SATURATION ABNORMAL 28 0.0099
206 ASPIRATION 108 0.0099
207 MOUTH HAEMORRHAGE 71 0.0097
208 INFLAMMATORY MARKER INCREASED 48 0.0097
209 PULMONARY ALVEOLAR HAEMORRHAGE 54 0.0096
210 DEPRESSED LEVEL OF CONSCIOUSNESS 378 0.0095
211 FOREIGN BODY IN THROAT 30 0.0095
212 BLOOD PHOSPHORUS INCREASED 26 0.0095
213 SENSITIVITY TO WEATHER CHANGE 50 0.0095
214 SLEEP APNOEA SYNDROME 181 0.0095
215 ADRENAL INSUFFICIENCY 115 0.0095
216 EYE HAEMORRHAGE 126 0.0094
217 HEPATIC ENZYME ABNORMAL 47 0.0094
218 VITAMIN B12 DECREASED 27 0.0094
219 HYPOXIA 327 0.0093
220 AORTIC STENOSIS 32 0.0092
221 CLUMSINESS 25 0.0092
222 POLYMYALGIA RHEUMATICA 29 0.0091
223 NEUROLOGICAL SYMPTOM 52 0.0091
224 ARTHRITIS 715 0.0091
225 HIGH DENSITY LIPOPROTEIN DECREASED 30 0.0090
226 COUGH 2525 0.0090
227 ATAXIA 106 0.0089
228 PULMONARY PAIN 26 0.0089
229 CORONARY ARTERY DISEASE 268 0.0088
230 CARDIAC FAILURE CHRONIC 37 0.0087
231 RESPIRATORY RATE INCREASED 77 0.0087
232 LOW DENSITY LIPOPROTEIN INCREASED 66 0.0085
233 VASCULITIS 99 0.0085
234 OXYGEN SATURATION DECREASED 475 0.0084
235 BLOOD CHOLESTEROL ABNORMAL 39 0.0084
236 INCREASED UPPER AIRWAY SECRETION 43 0.0084
237 HAEMOPTYSIS 233 0.0083
238 PERIPHERAL VASCULAR DISORDER 43 0.0083
239 RHINITIS 67 0.0083
240 OSTEOARTHRITIS 352 0.0083
241 ASTHMATIC CRISIS 30 0.0082
242 LIVER FUNCTION TEST INCREASED 176 0.0082
243 CATARACT 488 0.0082
244 MIDDLE INSOMNIA 152 0.0081
245 MYOSITIS 73 0.0081
246 BLOOD PRESSURE INCREASED 1240 0.0081
247 CATARACT OPERATION 48 0.0081
248 EUGLYCAEMIC DIABETIC KETOACIDOSIS 33 0.0080
249 MUSCLE CONTRACTIONS INVOLUNTARY 28 0.0080
250 MOBILITY DECREASED 569 0.0079
251 LISTLESS 26 0.0079
252 TENDERNESS 82 0.0079
253 BALANCE DISORDER 678 0.0078
254 POOR VENOUS ACCESS 81 0.0078
255 EYE PAIN 441 0.0078
256 RHINORRHOEA 505 0.0078
257 DYSARTHRIA 294 0.0078
258 SWELLING OF EYELID 49 0.0078
259 NERVE COMPRESSION 72 0.0078
260 GRANULOMA 27 0.0078
261 VENTRICULAR HYPOKINESIA 25 0.0078
262 RHEUMATOID ARTHRITIS 879 0.0077
263 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 547 0.0077
264 JOINT EFFUSION 53 0.0077
265 HEART RATE DECREASED 267 0.0076
266 LOWER RESPIRATORY TRACT INFECTION 345 0.0076
267 OCULAR DISCOMFORT 85 0.0076
268 CORONARY ARTERY OCCLUSION 103 0.0075
269 CHEST DISCOMFORT 768 0.0075
270 LEFT VENTRICULAR HYPERTROPHY 32 0.0075
271 PERICARDIAL EFFUSION 172 0.0074
272 PULSELESS ELECTRICAL ACTIVITY 31 0.0074
273 OROPHARYNGEAL DISCOMFORT 67 0.0074
274 UPPER RESPIRATORY TRACT INFECTION 342 0.0074
275 BRONCHIOLITIS 26 0.0074
276 SKIN ULCER 189 0.0073
277 PHARYNGITIS 90 0.0072
278 PNEUMOTHORAX 115 0.0072
279 CHRONIC SINUSITIS 27 0.0072
280 DRUG INTOLERANCE 689 0.0071
281 NAIL DISCOLOURATION 28 0.0071
282 TRANSAMINASES INCREASED 158 0.0071
283 HYPERVOLAEMIA 35 0.0071
284 DERMATITIS ALLERGIC 89 0.0071
285 TYPE 2 DIABETES MELLITUS 236 0.0070
286 SINUSITIS 715 0.0070
287 SCIATICA 111 0.0070
288 JOINT SWELLING 839 0.0069
289 GINGIVAL PAIN 55 0.0069
290 PRODUCT ADMINISTRATION INTERRUPTED 54 0.0069
291 MUSCULOSKELETAL DISCOMFORT 118 0.0068
292 URINE ABNORMALITY 31 0.0068
293 BLOOD ALBUMIN DECREASED 54 0.0068
294 RENAL CYST 54 0.0068
295 LYMPHOEDEMA 47 0.0068
296 GASTROOESOPHAGEAL REFLUX DISEASE 546 0.0068
297 HERNIA 130 0.0067
298 NASOPHARYNGITIS 1237 0.0067
299 JOINT RANGE OF MOTION DECREASED 90 0.0067
300 MYALGIA 1138 0.0067
301 MUSCLE RUPTURE 26 0.0067
302 HEAD DISCOMFORT 118 0.0067
303 CONTRAINDICATED PRODUCT ADMINISTERED 199 0.0066
304 CHRONIC LYMPHOCYTIC LEUKAEMIA 31 0.0065
305 NASAL CONGESTION 382 0.0065
306 BLOOD CREATINE PHOSPHOKINASE INCREASED 187 0.0065
307 EYE INFECTION 73 0.0065
308 APHASIA 195 0.0065
309 BLOOD TRIGLYCERIDES INCREASED 114 0.0064
310 MUSCULOSKELETAL STIFFNESS 564 0.0064
311 CENTRAL NERVOUS SYSTEM LESION 88 0.0064
312 ORAL HERPES 125 0.0064
313 DIZZINESS POSTURAL 62 0.0064
314 C-REACTIVE PROTEIN INCREASED 231 0.0063
315 OESOPHAGEAL PAIN 25 0.0063
316 PHOTOPHOBIA 119 0.0063
317 FOOT DEFORMITY 70 0.0063
318 ANGINA UNSTABLE 41 0.0063
319 SYNOVIAL CYST 29 0.0063
320 BLOOD CHOLESTEROL INCREASED 288 0.0062
321 HYPERTHYROIDISM 89 0.0061
322 ROTATOR CUFF SYNDROME 78 0.0061
323 THROAT IRRITATION 272 0.0061
324 SYNOVITIS 109 0.0060
325 HYPERLIPIDAEMIA 72 0.0060
326 GAMMA-GLUTAMYLTRANSFERASE INCREASED 133 0.0060
327 LIVER INJURY 147 0.0060
328 CHOKING SENSATION 33 0.0060
329 PNEUMONIA 1932 0.0060
330 PRODUCT DISTRIBUTION ISSUE 55 0.0059
331 DRUG-INDUCED LIVER INJURY 186 0.0059
332 MUSCLE ATROPHY 75 0.0059
333 FEEDING DISORDER 120 0.0059
334 ENTEROCOLITIS 34 0.0059
335 DENTAL CARIES 65 0.0059
336 PERIPHERAL SWELLING 900 0.0058
337 FOOT FRACTURE 110 0.0058
338 HORDEOLUM 25 0.0058
339 GLOMERULAR FILTRATION RATE DECREASED 71 0.0058
340 ARTHROPATHY 321 0.0058
341 CORONARY ARTERY STENOSIS 29 0.0058
342 BRAIN FOG 90 0.0057
343 DIVERTICULITIS 159 0.0057
344 HYPOTENSION 1142 0.0057
345 TOOTH INFECTION 75 0.0057
346 BLOOD PRESSURE ABNORMAL 113 0.0057
347 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 296 0.0057
348 RHINITIS ALLERGIC 25 0.0056
349 DERMATITIS CONTACT 64 0.0056
350 PAROSMIA 42 0.0056
351 RESTLESS LEGS SYNDROME 101 0.0055
352 CONCUSSION 43 0.0055
353 ATRIAL FIBRILLATION 540 0.0055
354 GLAUCOMA 106 0.0055
355 NASAL POLYPS 27 0.0055
356 BACK DISORDER 89 0.0055
357 SARCOIDOSIS 26 0.0055
358 MUSCULOSKELETAL PAIN 286 0.0055
359 MOVEMENT DISORDER 175 0.0054
360 VITAMIN D DECREASED 46 0.0054
361 BLOOD POTASSIUM DECREASED 161 0.0053
362 LARGE INTESTINE POLYP 37 0.0053
363 BLOOD IRON DECREASED 63 0.0053
364 INFLUENZA 591 0.0053
365 ERECTILE DYSFUNCTION 136 0.0053
366 TENDONITIS 82 0.0053
367 JOINT INJURY 113 0.0053
368 SKIN ABRASION 25 0.0053
369 FACIAL PAIN 47 0.0053
370 LUNG DISORDER 258 0.0053
371 WEIGHT FLUCTUATION 55 0.0053
372 DIABETES MELLITUS INADEQUATE CONTROL 93 0.0052
373 HYPOKINESIA 76 0.0052
374 IMPAIRED QUALITY OF LIFE 75 0.0052
375 BRONCHITIS 384 0.0052
376 BRONCHOSPASM 74 0.0052
377 DYSPHONIA 303 0.0052
378 ATELECTASIS 50 0.0052
379 HEPATIC FUNCTION ABNORMAL 193 0.0052
380 DYSPNOEA 2926 0.0052
381 PULMONARY OEDEMA 231 0.0052
382 MUSCULOSKELETAL CHEST PAIN 79 0.0051
383 INSURANCE ISSUE 78 0.0051
384 INFUSION RELATED REACTION 338 0.0051
385 DECREASED ACTIVITY 55 0.0051
386 LACRIMATION INCREASED 154 0.0051
387 THERAPEUTIC PRODUCT EFFECT DECREASED 226 0.0050
388 HYPOTHYROIDISM 161 0.0050
389 BLOOD CREATININE INCREASED 329 0.0050
390 HYPERGLYCAEMIA 183 0.0050
391 TOOTH FRACTURE 55 0.0050
392 OROPHARYNGEAL PAIN 460 0.0050
393 LOCALISED INFECTION 120 0.0050
394 CONSTIPATION 1082 0.0050
395 MUSCULAR WEAKNESS 563 0.0049
396 ABSCESS 79 0.0049
397 HAEMATOCRIT DECREASED 98 0.0049
398 POLYARTHRITIS 26 0.0049
399 SKIN EXFOLIATION 416 0.0049
400 VITAMIN D DEFICIENCY 48 0.0049
401 APATHY 71 0.0049
402 FOREIGN BODY SENSATION IN EYES 31 0.0049
403 EYE DISCHARGE 50 0.0048
404 HERPES ZOSTER 276 0.0048
405 INTERVERTEBRAL DISC PROTRUSION 105 0.0048
406 GASTROINTESTINAL DISORDER 430 0.0048
407 CARDIOMEGALY 59 0.0048
408 EAR DISCOMFORT 49 0.0048
409 INTERVERTEBRAL DISC DEGENERATION 44 0.0048
410 LUNG INFILTRATION 42 0.0048
411 CHEST PAIN 873 0.0047
412 DIABETES MELLITUS 359 0.0047
413 INJECTION SITE EXTRAVASATION 58 0.0047
414 FAECES SOFT 34 0.0047
415 HEART RATE INCREASED 459 0.0046
416 IMMUNODEFICIENCY 69 0.0046
417 OSTEOPOROSIS 189 0.0046
418 NEPHROLITHIASIS 210 0.0046
419 EMPHYSEMA 46 0.0046
420 LIVER DISORDER 202 0.0046
421 INFLAMMATION 235 0.0045
422 EAR INFECTION 121 0.0045
423 FALL 1512 0.0045
424 PALPITATIONS 532 0.0045
425 PHOTOSENSITIVITY REACTION 75 0.0045
426 TRANSIENT ISCHAEMIC ATTACK 152 0.0045
427 WEIGHT DECREASED 1257 0.0045
428 EAR PAIN 87 0.0045
429 PAIN IN EXTREMITY 1317 0.0045
430 SKIN INFECTION 50 0.0045
431 ALANINE AMINOTRANSFERASE INCREASED 273 0.0044
432 HOT FLUSH 335 0.0044
433 SPINAL OSTEOARTHRITIS 39 0.0044
434 POLLAKIURIA 184 0.0044
435 WALKING AID USER 29 0.0044
436 HYPERTENSION 925 0.0044
437 URINE OUTPUT DECREASED 38 0.0043
438 ACUTE CORONARY SYNDROME 36 0.0043
439 PHARYNGITIS STREPTOCOCCAL 47 0.0043
440 BONE DISORDER 79 0.0043
441 SKIN REACTION 61 0.0043
442 ARTHRALGIA 1798 0.0043
443 SLUGGISHNESS 44 0.0043
444 NASAL DRYNESS 27 0.0043
445 POST PROCEDURAL INFECTION 35 0.0043
446 LIMB DISCOMFORT 133 0.0043
447 EYE DISORDER 141 0.0043
448 NEUROPATHY PERIPHERAL 406 0.0043
449 BLOOD URINE PRESENT 81 0.0043
450 TEMPERATURE INTOLERANCE 44 0.0043
451 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 73 0.0043
452 MUSCLE SPASMS 781 0.0043
453 DRY EYE 212 0.0042
454 SKIN FISSURES 83 0.0042
455 PELVIC FRACTURE 33 0.0042
456 PSORIATIC ARTHROPATHY 172 0.0042
457 WHITE BLOOD CELL COUNT ABNORMAL 27 0.0042
458 GLUCOSE TOLERANCE IMPAIRED 25 0.0042
459 GASTROENTERITIS VIRAL 76 0.0042
460 SINUS HEADACHE 25 0.0042
461 MUSCLE DISORDER 34 0.0042
462 ASPARTATE AMINOTRANSFERASE INCREASED 223 0.0042
463 CHOLANGITIS 26 0.0042
464 HAND DEFORMITY 55 0.0042
465 SKIN MASS 28 0.0042
466 TINNITUS 192 0.0042
467 PAIN 2562 0.0042
468 NECK PAIN 232 0.0041
469 COVID-19 PNEUMONIA 49 0.0041
470 ILLNESS 426 0.0041
471 KNEE ARTHROPLASTY 87 0.0041
472 APHTHOUS ULCER 32 0.0041
473 FIBROMYALGIA 100 0.0041
474 TUBULOINTERSTITIAL NEPHRITIS 77 0.0041
475 SWELLING 383 0.0041
476 GLYCOSYLATED HAEMOGLOBIN INCREASED 103 0.0041
477 SCRATCH 43 0.0041
478 ECZEMA 213 0.0041
479 LEUKAEMIA 38 0.0040
480 HEPATIC STEATOSIS 75 0.0040
481 OSTEOPENIA 61 0.0040
482 ATRIAL FLUTTER 32 0.0040
483 VERTIGO 244 0.0040
484 ULCER HAEMORRHAGE 27 0.0040
485 TENDON DISORDER 26 0.0040
486 BLOOD ALKALINE PHOSPHATASE INCREASED 99 0.0040
487 INTERSTITIAL LUNG DISEASE 192 0.0040
488 OBESITY 63 0.0040
489 HAND FRACTURE 28 0.0039
490 BLADDER DISORDER 39 0.0039
491 CARPAL TUNNEL SYNDROME 55 0.0039
492 WRIST FRACTURE 47 0.0039
493 DRUG EFFECT LESS THAN EXPECTED 58 0.0039
494 ANAL INCONTINENCE 35 0.0039
495 GAIT INABILITY 130 0.0039
496 PHARYNGEAL SWELLING 38 0.0039
497 PAIN IN JAW 110 0.0039
498 GENERALISED OEDEMA 48 0.0039
499 OCULAR HYPERAEMIA 184 0.0039
500 CARDIAC FLUTTER 25 0.0039
501 LIMB INJURY 105 0.0039
502 BASAL CELL CARCINOMA 60 0.0038
503 RED BLOOD CELL COUNT DECREASED 109 0.0038
504 HEPATOCELLULAR INJURY 54 0.0038
505 ORAL CANDIDIASIS 50 0.0038
506 ACUTE KIDNEY INJURY 581 0.0038
507 DRUG INTERACTION 602 0.0038
508 HEPATITIS 97 0.0038
509 RENAL IMPAIRMENT 318 0.0038
510 DRY MOUTH 307 0.0038
511 TRICUSPID VALVE INCOMPETENCE 30 0.0038
512 STOMATITIS 229 0.0038
513 COVID-19 662 0.0038
514 PSORIASIS 492 0.0038
515 IMMUNOSUPPRESSION 33 0.0037
516 ASTHENIA 1400 0.0037
517 ABDOMINAL PAIN UPPER 765 0.0037
518 PEMPHIGOID 28 0.0037
519 JOINT STIFFNESS 97 0.0037
520 BRADYCARDIA 196 0.0037
521 DRUG SPECIFIC ANTIBODY PRESENT 24 0.0037
522 TOOTH DISORDER 82 0.0037
523 INFLUENZA LIKE ILLNESS 303 0.0037
524 CARDIAC DISORDER 344 0.0037
525 BLOOD PRESSURE DECREASED 244 0.0037
526 SPINAL PAIN 43 0.0037
527 NEOPLASM 42 0.0037
528 AGEUSIA 91 0.0036
529 SKIN LESION 100 0.0036
530 URINARY TRACT INFECTION 621 0.0036
531 HAEMORRHOIDS 71 0.0036
532 SLEEP DISORDER 256 0.0036
533 THERAPY NON-RESPONDER 163 0.0036
534 LYMPHOCYTE COUNT DECREASED 64 0.0036
535 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 652 0.0036
536 FATIGUE 2815 0.0036
537 NEUTROPHIL COUNT INCREASED 37 0.0036
538 DISCOMFORT 220 0.0036
539 MYOCARDIAL ISCHAEMIA 41 0.0036
540 IMPAIRED GASTRIC EMPTYING 49 0.0036
541 INCREASED TENDENCY TO BRUISE 33 0.0036
542 MUSCLE STRAIN 31 0.0036
543 LEFT VENTRICULAR DYSFUNCTION 24 0.0036
544 MIGRAINE 342 0.0036
545 HEADACHE 2235 0.0036
546 HEPATIC ENZYME INCREASED 243 0.0036
547 DYSSTASIA 104 0.0036
548 SKIN PLAQUE 30 0.0036
549 ORAL DISORDER 26 0.0035
550 FURUNCLE 28 0.0035
551 POOR QUALITY SLEEP 76 0.0035
552 BLOOD UREA INCREASED 59 0.0035
553 DIVERTICULUM 25 0.0035
554 NEEDLE ISSUE 102 0.0035
555 CHRONIC KIDNEY DISEASE 266 0.0035
556 CARDIAC FAILURE 281 0.0035
557 DRUG ERUPTION 62 0.0035
558 EYE IRRITATION 200 0.0035
559 INTENTIONAL DOSE OMISSION 99 0.0035
560 MALAISE 1521 0.0035
561 FRUSTRATION TOLERANCE DECREASED 28 0.0035
562 HAEMATOCHEZIA 191 0.0035
563 ANAPHYLACTIC REACTION 191 0.0035
564 BACK PAIN 803 0.0035
565 DYSPHAGIA 328 0.0035
566 INCREASED APPETITE 66 0.0035
567 PLATELET COUNT INCREASED 45 0.0034
568 RASH PRURITIC 187 0.0034
569 SKIN DISCOLOURATION 158 0.0034
570 PRODUCT DOSE OMISSION ISSUE 1010 0.0034
571 CELLULITIS 173 0.0034
572 DEFAECATION URGENCY 24 0.0034
573 PRURITUS 1316 0.0034
574 THROMBOSIS 275 0.0034
575 AORTIC ANEURYSM 26 0.0034
576 PRODUCT ADMINISTRATION ERROR 69 0.0034
577 PULMONARY CONGESTION 45 0.0034
578 SARS-COV-2 TEST POSITIVE 45 0.0034
579 HYPOAESTHESIA 506 0.0034
580 FREQUENT BOWEL MOVEMENTS 91 0.0034
581 EYE PRURITUS 113 0.0034
582 EYE SWELLING 125 0.0034
583 EPISTAXIS 251 0.0034
584 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 24 0.0033
585 ORAL PAIN 75 0.0033
586 STENT PLACEMENT 27 0.0033
587 CONTUSION 322 0.0033
588 MYASTHENIA GRAVIS 27 0.0033
589 PLATELET COUNT DECREASED 356 0.0033
590 INTENTIONAL PRODUCT USE ISSUE 292 0.0033
591 HAEMOGLOBIN DECREASED 342 0.0033
592 CHROMATURIA 75 0.0033
593 WEIGHT INCREASED 744 0.0033
594 KIDNEY INFECTION 65 0.0033
595 HYPERKALAEMIA 116 0.0033
596 FLUID RETENTION 168 0.0033
597 TASTE DISORDER 67 0.0033
598 OVARIAN CYST 33 0.0033
599 GINGIVAL BLEEDING 45 0.0033
600 BODY HEIGHT DECREASED 35 0.0033
601 VOMITING 1538 0.0033
602 MITRAL VALVE INCOMPETENCE 37 0.0033
603 PROSTATIC SPECIFIC ANTIGEN INCREASED 45 0.0033
604 THERAPEUTIC RESPONSE DECREASED 198 0.0033
605 TOOTHACHE 59 0.0033
606 HIATUS HERNIA 42 0.0032
607 FEELING COLD 90 0.0032
608 ABDOMINAL DISCOMFORT 541 0.0032
609 RESPIRATORY SYNCYTIAL VIRUS INFECTION 28 0.0032
610 HYPOALBUMINAEMIA 25 0.0032
611 PERIPHERAL COLDNESS 44 0.0032
612 PLEURAL EFFUSION 194 0.0032
613 HYPOKALAEMIA 147 0.0032
614 PRODUCT DOSE OMISSION IN ERROR 90 0.0032
615 SWOLLEN TONGUE 99 0.0032
616 ILL-DEFINED DISORDER 192 0.0032
617 RENAL TUBULAR NECROSIS 31 0.0032
618 RIB FRACTURE 65 0.0032
619 PSEUDOMONAS INFECTION 27 0.0031
620 HYPERSENSITIVITY 584 0.0031
621 CARDIAC FAILURE CONGESTIVE 252 0.0031
622 BLOOD MAGNESIUM DECREASED 27 0.0031
623 LABORATORY TEST ABNORMAL 92 0.0031
624 SKIN SWELLING 27 0.0031
625 OEDEMA PERIPHERAL 378 0.0031
626 IMPAIRED WORK ABILITY 66 0.0031
627 SPINAL OPERATION 38 0.0031
628 DISABILITY 61 0.0031
629 NEURALGIA 75 0.0031
630 APHONIA 43 0.0031
631 CEREBRAL INFARCTION 75 0.0031
632 VENTRICULAR FIBRILLATION 34 0.0031
633 CONDITION AGGRAVATED 930 0.0031
634 URINARY RETENTION 102 0.0031
635 HEART RATE IRREGULAR 69 0.0031
636 DRY THROAT 31 0.0030
637 PRODUCT USE COMPLAINT 48 0.0030
638 EYE INFLAMMATION 29 0.0030
639 SKIN DISORDER 101 0.0030
640 UVEITIS 41 0.0030
641 MYOCARDIAL INFARCTION 526 0.0030
642 FRACTURE 57 0.0030
643 PRESCRIBED UNDERDOSE 60 0.0030
644 CEREBROVASCULAR ACCIDENT 509 0.0030
645 BLOOD BILIRUBIN INCREASED 81 0.0030
646 FLANK PAIN 28 0.0030
647 BLOOD GLUCOSE INCREASED 562 0.0030
648 SCAB 34 0.0030
649 ANXIETY 846 0.0030
650 ANKLE FRACTURE 46 0.0030
651 EXPOSURE VIA SKIN CONTACT 77 0.0030
652 METABOLIC ACIDOSIS 95 0.0030
653 CANDIDA INFECTION 50 0.0030
654 DRY SKIN 394 0.0029
655 PULMONARY EMBOLISM 280 0.0029
656 RASH MACULAR 103 0.0029
657 PNEUMONIA BACTERIAL 27 0.0029
658 HEAD INJURY 93 0.0029
659 LIGAMENT SPRAIN 29 0.0029
660 ABNORMAL FAECES 24 0.0029
661 DIZZINESS 1457 0.0029
662 ACUTE RESPIRATORY FAILURE 56 0.0029
663 BURNING SENSATION 204 0.0029
664 CARDIAC OPERATION 25 0.0029
665 ANURIA 25 0.0029
666 INSOMNIA 773 0.0029
667 CYST 36 0.0029
668 GOUT 52 0.0029
669 GAIT DISTURBANCE 554 0.0029
670 MULTIPLE FRACTURES 47 0.0029
671 PERICARDITIS 48 0.0029
672 INJECTION SITE INDURATION 37 0.0029
673 ACUTE MYOCARDIAL INFARCTION 84 0.0028
674 BODY TEMPERATURE INCREASED 58 0.0028
675 CONFUSIONAL STATE 459 0.0028
676 EYELID OEDEMA 33 0.0028
677 TENDON RUPTURE 35 0.0028
678 PULMONARY HYPERTENSION 59 0.0028
679 DIARRHOEA 1828 0.0028
680 RENAL PAIN 30 0.0028
681 BLOOD THYROID STIMULATING HORMONE INCREASED 26 0.0028
682 HYPOGLYCAEMIA 137 0.0028
683 THERAPY PARTIAL RESPONDER 44 0.0028
684 NIGHTMARE 97 0.0028
685 DERMATITIS ATOPIC 147 0.0028
686 PROTEINURIA 53 0.0028
687 BLOOD POTASSIUM INCREASED 45 0.0028
688 RENAL DISORDER 129 0.0028
689 FLATULENCE 157 0.0028
690 DECREASED APPETITE 643 0.0028
691 BLOOD GLUCOSE ABNORMAL 51 0.0028
692 PULMONARY ARTERIAL HYPERTENSION 40 0.0028
693 DEMENTIA 77 0.0028
694 TREATMENT FAILURE 227 0.0027
695 BEDRIDDEN 36 0.0027
696 BLOOD GLUCOSE FLUCTUATION 30 0.0027
697 PEMPHIGUS 34 0.0027
698 ABDOMINAL PAIN 632 0.0027
699 PRODUCT USE IN UNAPPROVED INDICATION 670 0.0027
700 PYREXIA 931 0.0027
701 CHOLECYSTITIS 32 0.0027
702 DYSPEPSIA 264 0.0027
703 GASTROINTESTINAL INFECTION 24 0.0027
704 WHITE BLOOD CELL COUNT DECREASED 288 0.0027
705 EJECTION FRACTION DECREASED 41 0.0026
706 PRESYNCOPE 64 0.0026
707 RECTAL HAEMORRHAGE 113 0.0026
708 THERAPEUTIC RESPONSE SHORTENED 87 0.0026
709 MOUTH ULCERATION 55 0.0026
710 STAPHYLOCOCCAL INFECTION 86 0.0026
711 NAUSEA 2063 0.0026
712 IRON DEFICIENCY ANAEMIA 24 0.0026
713 GASTRITIS 68 0.0026
714 IMMUNE SYSTEM DISORDER 34 0.0026
715 BACK INJURY 28 0.0026
716 RESPIRATORY DISORDER 77 0.0026
717 PNEUMONITIS 70 0.0026
718 SCAR 44 0.0026
719 DISEASE RECURRENCE 122 0.0026
720 HYPERHIDROSIS 330 0.0026
721 SYNCOPE 256 0.0026
722 VIRAL INFECTION 85 0.0026
723 LOWER LIMB FRACTURE 49 0.0025
724 MEMORY IMPAIRMENT 350 0.0025
725 TOXICITY TO VARIOUS AGENTS 428 0.0025
726 RETCHING 54 0.0025
727 URINARY INCONTINENCE 75 0.0025
728 DEHYDRATION 337 0.0025
729 GASTRIC ULCER 48 0.0025
730 ARRHYTHMIA 119 0.0025
731 TREMOR 417 0.0025
732 COLITIS 95 0.0025
733 BLOOD SODIUM DECREASED 47 0.0025
734 DEAFNESS 65 0.0025
735 FULL BLOOD COUNT DECREASED 50 0.0025
736 ERUCTATION 48 0.0025
737 BONE PAIN 145 0.0025
738 END STAGE RENAL DISEASE 45 0.0025
739 HIP FRACTURE 79 0.0025
740 HALLUCINATION, AUDITORY 39 0.0025
741 THERAPY INTERRUPTED 175 0.0024
742 FAECES DISCOLOURED 53 0.0024
743 HYPOACUSIS 105 0.0024
744 CLOSTRIDIUM DIFFICILE INFECTION 53 0.0024
745 VENTRICULAR EXTRASYSTOLES 25 0.0024
746 ABDOMINAL DISTENSION 251 0.0024
747 NEUTROPHIL COUNT DECREASED 98 0.0024
748 FUNGAL INFECTION 80 0.0024
749 ORAL DISCOMFORT 33 0.0024
750 HYPERSOMNIA 68 0.0024
751 RASH 1032 0.0024
752 JOINT DISLOCATION 25 0.0024
753 DEPRESSED MOOD 125 0.0024
754 ERYTHEMA 484 0.0024
755 BREAST PAIN 25 0.0023
756 INITIAL INSOMNIA 24 0.0023
757 DYSURIA 86 0.0023
758 VISION BLURRED 320 0.0023
759 LIP SWELLING 77 0.0023
760 GALLBLADDER DISORDER 41 0.0023
761 MUSCLE TIGHTNESS 37 0.0023
762 ASCITES 67 0.0023
763 WHITE BLOOD CELL COUNT INCREASED 87 0.0023
764 ULCER 36 0.0023
765 ALTERED STATE OF CONSCIOUSNESS 49 0.0023
766 GASTROENTERITIS 33 0.0023
767 DEVICE DISLOCATION 98 0.0023
768 TOOTH EXTRACTION 28 0.0022
769 DYSGEUSIA 167 0.0022
770 ELECTROLYTE IMBALANCE 26 0.0022
771 CARDIOMYOPATHY 33 0.0022
772 HYPOPHAGIA 57 0.0022
773 SKIN CANCER 48 0.0022
774 NEPHROPATHY TOXIC 25 0.0022
775 URTICARIA 373 0.0022
776 PARAESTHESIA 348 0.0022
777 VISUAL IMPAIRMENT 274 0.0022
778 DEPRESSION 503 0.0022
779 DEVICE OCCLUSION 31 0.0022
780 ANKYLOSING SPONDYLITIS 29 0.0022
781 UPPER GASTROINTESTINAL HAEMORRHAGE 37 0.0022
782 ACCIDENTAL OVERDOSE 80 0.0022
783 ANAEMIA 415 0.0022
784 LYMPHADENOPATHY 77 0.0022
785 TACHYCARDIA 192 0.0022
786 INFECTION 311 0.0021
787 LOSS OF CONSCIOUSNESS 275 0.0021
788 BLOOD LACTATE DEHYDROGENASE INCREASED 34 0.0021
789 SYSTEMIC LUPUS ERYTHEMATOSUS 76 0.0021
790 ISCHAEMIC STROKE 38 0.0021
791 GASTRIC DISORDER 73 0.0021
792 PRODUCT AVAILABILITY ISSUE 48 0.0021
793 COLITIS ULCERATIVE 93 0.0021
794 PSYCHOTIC DISORDER 61 0.0021
795 MELAENA 45 0.0020
796 CHOLELITHIASIS 67 0.0020
797 HEPATIC CIRRHOSIS 38 0.0020
798 HALLUCINATION 152 0.0020
799 HAEMATURIA 69 0.0020
800 ILEUS 25 0.0020
801 UPPER LIMB FRACTURE 40 0.0020
802 DERMATITIS 42 0.0020
803 RESPIRATORY FAILURE 146 0.0020
804 HYPONATRAEMIA 112 0.0020
805 CEREBRAL HAEMORRHAGE 71 0.0020
806 OFF LABEL USE 1729 0.0020
807 LIVER FUNCTION TEST ABNORMAL 57 0.0020
808 FEELING ABNORMAL 469 0.0020
809 NIGHT SWEATS 63 0.0020
810 AMNESIA 127 0.0020
811 PRODUCT USE ISSUE 365 0.0019
812 ABDOMINAL PAIN LOWER 49 0.0019
813 DRUG INEFFECTIVE 2551 0.0019
814 MASS 27 0.0019
815 SEPTIC SHOCK 84 0.0019
816 FLUSHING 195 0.0019
817 BLOOD GLUCOSE DECREASED 92 0.0019
818 BLISTER 107 0.0019
819 RENAL FAILURE 252 0.0019
820 GENERAL PHYSICAL HEALTH DETERIORATION 219 0.0019
821 MALIGNANT NEOPLASM PROGRESSION 193 0.0019
822 RASH ERYTHEMATOUS 90 0.0019
823 CARDIOGENIC SHOCK 27 0.0019
824 PALLOR 51 0.0019
825 PARAESTHESIA ORAL 27 0.0019
826 SPEECH DISORDER 98 0.0019
827 MEDICATION ERROR 103 0.0019
828 ENCEPHALOPATHY 45 0.0018
829 SURGERY 107 0.0018
830 MULTIPLE SCLEROSIS RELAPSE 125 0.0018
831 POST PROCEDURAL COMPLICATION 35 0.0018
832 CHILLS 213 0.0018
833 COLD SWEAT 32 0.0018
834 DELIRIUM 63 0.0018
835 THROAT TIGHTNESS 49 0.0018
836 ADVERSE REACTION 24 0.0018
837 FEBRILE NEUTROPENIA 120 0.0018
838 INJECTION SITE SWELLING 138 0.0018
839 HYPOMAGNESAEMIA 25 0.0018
840 LACTIC ACIDOSIS 58 0.0018
841 HOSPITALISATION 275 0.0018
842 GLOSSODYNIA 40 0.0018
843 PERITONITIS 37 0.0018
844 INJECTION SITE BRUISING 142 0.0018
845 ADVERSE DRUG REACTION 159 0.0018
846 DEVICE MALFUNCTION 124 0.0018
847 SOMNOLENCE 355 0.0018
848 HIP ARTHROPLASTY 27 0.0018
849 SINUS TACHYCARDIA 25 0.0018
850 INJECTION SITE MASS 65 0.0018
851 WOUND 49 0.0018
852 INJECTION SITE WARMTH 36 0.0017
853 SPINAL FRACTURE 35 0.0017
854 CHOKING 34 0.0017
855 MUSCULOSKELETAL DISORDER 33 0.0017
856 PRODUCT PRESCRIBING ERROR 41 0.0017
857 PNEUMONIA ASPIRATION 43 0.0017
858 ANGIOEDEMA 75 0.0017
859 INJECTION SITE RASH 52 0.0017
860 SEPSIS 189 0.0017
861 MYELOSUPPRESSION 61 0.0017
862 PANCREATITIS ACUTE 38 0.0017
863 MOOD ALTERED 46 0.0017
864 THIRST 30 0.0017
865 DRUG RESISTANCE 43 0.0017
866 CONJUNCTIVITIS 31 0.0017
867 DEVICE USE ISSUE 29 0.0017
868 OSTEOMYELITIS 30 0.0017
869 COMPLICATION ASSOCIATED WITH DEVICE 24 0.0017
870 PELVIC PAIN 30 0.0016
871 JAUNDICE 44 0.0016
872 INTENTIONAL PRODUCT MISUSE 143 0.0016
873 PRODUCT SUBSTITUTION ISSUE 94 0.0016
874 IRRITABLE BOWEL SYNDROME 35 0.0016
875 INJECTION SITE PAIN 499 0.0016
876 HAEMATOMA 42 0.0016
877 INTESTINAL OBSTRUCTION 61 0.0016
878 INJECTION SITE PRURITUS 108 0.0016
879 RESTLESSNESS 59 0.0016
880 BACTERIAL INFECTION 30 0.0016
881 PRODUCT DISPENSING ERROR 35 0.0016
882 LEUKOCYTOSIS 29 0.0016
883 PRODUCT PHYSICAL ISSUE 32 0.0016
884 DIABETIC KETOACIDOSIS 38 0.0016
885 INTERNATIONAL NORMALISED RATIO INCREASED 45 0.0016
886 RESPIRATORY DISTRESS 43 0.0016
887 SWELLING FACE 101 0.0015
888 NERVOUSNESS 81 0.0015
889 FEELING HOT 95 0.0015
890 INCORRECT DOSE ADMINISTERED 346 0.0015
891 LETHARGY 87 0.0015
892 ROAD TRAFFIC ACCIDENT 63 0.0015
893 FEMUR FRACTURE 46 0.0015
894 FACE OEDEMA 25 0.0015
895 ELECTROCARDIOGRAM QT PROLONGED 53 0.0015
896 FEELING JITTERY 28 0.0015
897 PRODUCT PRESCRIBING ISSUE 32 0.0015
898 PAIN OF SKIN 39 0.0014
899 BLINDNESS 59 0.0014
900 PRESCRIBED OVERDOSE 28 0.0014
901 ALOPECIA 284 0.0014
902 NEOPLASM PROGRESSION 50 0.0014
903 RASH PAPULAR 32 0.0014
904 INJECTION SITE ERYTHEMA 177 0.0014
905 INJECTION SITE URTICARIA 35 0.0014
906 DIPLOPIA 37 0.0014
907 TREATMENT NONCOMPLIANCE 77 0.0014
908 THERAPY CESSATION 72 0.0014
909 PANCREATITIS 74 0.0014
910 EMOTIONAL DISORDER 43 0.0014
911 MULTIPLE ORGAN DYSFUNCTION SYNDROME 39 0.0014
912 DISTURBANCE IN ATTENTION 74 0.0014
913 IMPAIRED HEALING 45 0.0014
914 MENTAL IMPAIRMENT 33 0.0014
915 CHOLESTASIS 26 0.0014
916 NEOPLASM MALIGNANT 90 0.0013
917 CRYING 49 0.0013
918 MUCOSAL INFLAMMATION 35 0.0013
919 PROCEDURAL PAIN 37 0.0013
920 HEPATIC FAILURE 40 0.0013
921 DEEP VEIN THROMBOSIS 86 0.0013
922 MULTIPLE SCLEROSIS 63 0.0013
923 UNDERDOSE 95 0.0013
924 EXPIRED PRODUCT ADMINISTERED 43 0.0013
925 HAEMORRHAGE 135 0.0013
926 PANCYTOPENIA 72 0.0013
927 DISORIENTATION 51 0.0013
928 ABNORMAL DREAMS 35 0.0013
929 RENAL FAILURE ACUTE 53 0.0012
930 AGITATION 89 0.0012
931 GASTROINTESTINAL HAEMORRHAGE 101 0.0012
932 PANIC ATTACK 44 0.0012
933 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 244 0.0012
934 SEIZURE 139 0.0012
935 IRRITABILITY 71 0.0012
936 ADVERSE EVENT 108 0.0012
937 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 30 0.0012
938 MOOD SWINGS 37 0.0012
939 SKIN IRRITATION 52 0.0011
940 CARDIAC ARREST 92 0.0011
941 EXTRA DOSE ADMINISTERED 45 0.0011
942 ACCIDENTAL EXPOSURE TO PRODUCT 113 0.0011
943 MENTAL DISORDER 47 0.0011
944 RENAL INJURY 32 0.0011
945 ANGER 36 0.0011
946 DYSKINESIA 43 0.0011
947 ANAPHYLACTIC SHOCK 27 0.0010
948 INJECTION SITE HAEMORRHAGE 83 0.0010
949 CARDIOVASCULAR DISORDER 26 0.0010
950 LUNG NEOPLASM MALIGNANT 42 0.0010
951 AGGRESSION 51 0.0010
952 UNEVALUABLE EVENT 77 0.0010
953 DEVICE LEAKAGE 44 0.0010
954 UNRESPONSIVE TO STIMULI 26 0.0010
955 ANHEDONIA 26 0.0010
956 ACNE 74 0.0010
957 PLASMA CELL MYELOMA 38 0.0010
958 SUICIDAL IDEATION 89 0.0010
959 NERVOUS SYSTEM DISORDER 30 0.0010
960 DRUG ABUSE 80 0.0010
961 SKIN BURNING SENSATION 68 0.0009
962 HAEMATEMESIS 24 0.0009
963 LEUKOPENIA 47 0.0009
964 NEUTROPENIA 126 0.0009
965 THROMBOCYTOPENIA 102 0.0009
966 DISEASE PROGRESSION 105 0.0009
967 OSTEONECROSIS 28 0.0009
968 VISUAL ACUITY REDUCED 28 0.0008
969 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 46 0.0008
970 DEVICE ISSUE 73 0.0008
971 PRODUCT DOSE OMISSION 52 0.0008
972 OVERDOSE 170 0.0008
973 DEATH 637 0.0007
974 PROSTATE CANCER 59 0.0007
975 INJECTION SITE REACTION 50 0.0007
976 CARDIO-RESPIRATORY ARREST 30 0.0007
977 THERAPEUTIC RESPONSE UNEXPECTED 31 0.0007
978 ABNORMAL BEHAVIOUR 27 0.0007
979 EMOTIONAL DISTRESS 76 0.0006
980 INJURY 42 0.0006
981 PRODUCT STORAGE ERROR 51 0.0006
982 BLADDER CANCER 34 0.0006
983 SUICIDE ATTEMPT 34 0.0006
984 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 26 0.0006
985 INTENTIONAL OVERDOSE 32 0.0005
986 BREAST CANCER 46 0.0005
987 DRUG EFFECT DECREASED 24 0.0004
988 DEVICE DIFFICULT TO USE 29 0.0004
989 COMPLETED SUICIDE 34 0.0004
990 DRUG DEPENDENCE 61 0.0004
991 PRODUCT QUALITY ISSUE 47 0.0003
992 NO ADVERSE EVENT 53 0.0003
993 DRUG DOSE OMISSION 27 0.0002